Haemonetics Corporation
HAE
$53.12
-$0.62-1.15%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.31% | 54.64% | 10.83% | -11.84% | 88.41% |
| Total Depreciation and Amortization | 33.71% | -25.90% | -0.66% | 0.28% | 53.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 194.95% | -236.50% | -50.14% | 197.87% | -558.23% |
| Change in Net Operating Assets | -235.35% | 234.24% | -2.35% | 62.22% | -727.12% |
| Cash from Operations | -85.08% | 166.32% | -10.36% | 278.05% | -142.79% |
| Capital Expenditure | 76.00% | -772.94% | 85.04% | -111.74% | 15.39% |
| Sale of Property, Plant, and Equipment | -87.88% | 876.49% | 32.80% | -99.07% | 3,595.46% |
| Cash Acquisitions | -- | -- | 100.00% | 98.82% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -144.99% | 23.82% | -61.12% | -106.76% | 43.58% |
| Cash from Investing | -282.93% | 203.85% | 25.66% | 83.21% | -966.15% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 0.00% | -0.06% | -101.77% | 115.01% | -825.61% |
| Issuance of Common Stock | 2,712.86% | -96.05% | 1,310.36% | -94.30% | 4,052.83% |
| Repurchase of Common Stock | 96.81% | -33,307.57% | 99.40% | -669.68% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.33% | 81.88% | 99.83% | -280.27% | -21,378.70% |
| Cash from Financing | 98.39% | -11,074.64% | 101.84% | -122.42% | 625.48% |
| Foreign Exchange rate Adjustments | 50.97% | 144.59% | -247.83% | 390.80% | 46.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.55% | -165.31% | 147.76% | -127.26% | 1,191.24% |